It is 2024. Is your laboratory using current breakpoints? Are you familiar with the requirements? This episode features a collaboration with Breakpoints: The SIDP Podcast. In it I join the podcast along with two other guests to talk about those requirements among other things.

Check out the Breakpoints podcast: https://sidp.pinecast.co

More information on breakpoints toolkit: https://clsi.org/meetings/ast/breakpoints-in-use-toolkit/

Originally published as episodes 36 and 37, in this episode I go over Streptococcus agalactiae. I discuss morphology, biochemicals, and testing among other things. What is the Lancefield group of this organism? What is the significance of this organism in neonates? Any organisms that morphologically resemble it? Tune in to find out.

Originally released as episode 53, in this episode I go over Enterococcus species. What are the most clinically significant species of Enterococcus? Morphology? Biochemicals? Tune in to find out more about these organisms, and why are they so significant in healthcare settings.

Originally released as episode 58, in this episode I continue going over S. pneumoniae. This time I go over a popular antigen test. I also discuss molecular testing, including limitations and the importance of correlating the gram stain with the result. Also, have you heard of Streptococcus pseudopneumoniae?

The AMR sub-series is back! Dr. Minkey Wungwattana joins Luis and Andrea in the podcast to talk about fluoroquinolones. What is the mechanism of action of this class of antimicrobials? What organisms do they have activity against? What about breakpoints for Salmonella? Tune in to find out.

Link to breakpoints episode that Andrea mentioned:

https://rss.com/podcasts/letstalkmicro/475955/

This episode was originally published as episode 57. In it I go over Streptococcus pneumoniae: gram stain, morphology, diseases, and more. What is optochin? What is the bile solubility test? Tune in to find out.

This episode features a conversation with Lisa Parlich, an Infection Preventionist, with a background in Medical Laboratory Sciences. Lisa joins the podcast to talk about an order for urinalysis that was implemented in her hospital. This order is the Urinalysis with Hold order panel. Those of you that work in the laboratory might be familiar with the Urinalysis with reflex to culture order, where if an urinalysis meets the positive criteria for a culture, an order for an urine culture is reflexed, How does this new order differ from traditional orders? How does it help the patients ? How does it work? Tune in to find out.

In this episode, Dr. Pei Zhou from the Duke University School of Medicine joins the podcast to talk about LPC-233. This is a compound that shows bactericidal activity against some gram-negative rods. LPC-233 is an LpxC inhibitor. What is LpxC? How does LPC-233 works? What are some challenges of developing LpxC inhibitors? Tune in to find out.

Link to article: https://doi.org/10.1126/scitranslmed.adf5668

Questions? Feedback? Send those to [email protected]

Want to support the podcast? Here's how:

Venmo: https://venmo.com/u/letstalkmicro

Buy me a Ko-fi: https://ko-fi.com/letstalkmicro

Originally released in 2021, in this episode I go over anaerobes. What are some examples of anaerobes? Why can't they grow aerobically ? What is a facultative anaerobe? Tune in to learn more.

In this episode I continue talking about MALDI-TOF MS. This time I go over the advantages and disadvantages. How has MALDI-TOF helped Clinical Microbiology? How does it compare to traditional identification methods and the workflow? What about disadvantages? Tune in to find out.